Institution
Treatment Action Group
Nonprofit•New York, New York, United States•
About: Treatment Action Group is a nonprofit organization based out in New York, New York, United States. It is known for research contribution in the topics: Tuberculosis & Acquired immunodeficiency syndrome (AIDS). The organization has 27 authors who have published 156 publications receiving 6063 citations.
Topics: Tuberculosis, Acquired immunodeficiency syndrome (AIDS), Bedaquiline, Population, Hepatitis C
Papers published on a yearly basis
Papers
More filters
TL;DR: It is proposed that the internationally recommended algorithm for the diagnosis of smear-negative pulmonary tuberculosis should be revised to include HIV status, severity of AIDS and tuberculosis, and early use of chest radiography in the decision tree.
532 citations
University of Cape Town1, Baylor University Medical Center2, Johns Hopkins University School of Medicine3, Harvard University4, Treatment Action Group5, Stellenbosch University6, Johns Hopkins University7, University of North Carolina at Chapel Hill8, University of Antwerp9, Hong Kong Polytechnic University10, University of London11, National Taiwan University12, Hong Kong Department of Health13, University of California, San Francisco14, Boston University15, South African Medical Research Council16, University of the Witwatersrand17, McGill University18, National Institutes of Health19, World Health Organization20, Treatment Action Campaign21, Centre for the AIDS Programme of Research in South Africa22
TL;DR: Several lines of evidence suggest that alternative mechanisms-including pharmacokinetic variability, induction of efflux pumps that transport the drug out of cells, and suboptimal drug penetration into tuberculosis lesions-are likely crucial to the pathogenesis of drug-resistant tuberculosis.
461 citations
TL;DR: This review synthesizes the state of engagement in HIV care in the United States, focusing on research, practice, and policy considerations, and includes a look to the future in addressing the greatest challenge and opportunity facing the authors' domestic HIV epidemic.
Abstract: The National HIV/AIDS Strategy and the promise of treatment as prevention have garnered considerable attention from the policy, practice, and scientific communities, with the treatment cascade becoming the sentinel image illustrating the domestic human immunodeficiency virus (HIV) epidemic. The cascade depicts prevalence estimates for sequential steps from HIV diagnosis through viral suppression, the most striking of which is that >50% of persons diagnosed with HIV are not in medical care. This heterogeneous group includes individuals not linked to medical care following HIV diagnosis and those entering care who are not retained, requiring reengagement from a range of community settings. This review synthesizes the state of engagement in HIV care in the United States, focusing on research, practice, and policy considerations. Included are conceptual frameworks, a review of health implications, measurement, monitoring, and evidence-based intervention approaches, and a look to the future in addressing the greatest challenge and opportunity facing our domestic HIV epidemic.
456 citations
University of California, San Francisco1, Royal Melbourne Hospital2, Walter Reed Army Institute of Research3, University of Montpellier4, University of Southern California5, Université de Montréal6, National Institutes of Health7, Leidos8, World Health Organization9, University of North Carolina at Chapel Hill10, University of Pittsburgh11, Johns Hopkins University School of Medicine12, Pasteur Institute13, Ragon Institute of MGH, MIT and Harvard14, University of Paris15, Beth Israel Deaconess Medical Center16, Hannover Medical School17, Necker-Enfants Malades Hospital18, University of Hong Kong19, Harvard University20, Imperial College London21, Treatment Action Group22, Fred Hutchinson Cancer Research Center23, Stellenbosch University24, University of Toronto25, Utrecht University26, University of Sydney27, University of California, San Diego28, Emory University29, University of KwaZulu-Natal30, French Institute of Health and Medical Research31, The Advisory Board Company32, Aarhus University33, Scripps Research Institute34, ViiV Healthcare35, Brown University36, University of California, Los Angeles37
TL;DR: A group of international experts to develop a scientific strategy for research towards an HIV cure summarized the group's strategy in this Perspective.
Abstract: Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy.
376 citations
TL;DR: The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million, although additional sources of potential underestimation suggest that the true prevalence could well be higher.
371 citations
Authors
Showing all 28 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Tracy Swan | 20 | 37 | 2327 |
| Paisan Suwannawong | 18 | 38 | 694 |
| Karyn Kaplan | 18 | 40 | 700 |
| Mark Harrington | 15 | 30 | 2119 |
| Gregg Gonsalves | 15 | 53 | 780 |
| Erica Lessem | 11 | 25 | 720 |
| Mike Frick | 10 | 21 | 250 |
| Jeremiah Johnson | 8 | 14 | 370 |
| Lindsay McKenna | 8 | 24 | 332 |
| Liz Barr | 7 | 10 | 94 |
| Tim Horn | 7 | 16 | 1069 |
| Richard Jefferys | 7 | 16 | 521 |
| Claire Wingfield | 6 | 7 | 544 |
| Colleen Daniels | 6 | 7 | 286 |
| Sattara Hattirat | 2 | 2 | 43 |